Modified Transurethral Incision of the Bladder Neck Treating Primary Bladder Neck Obstruction in Young Men: A Method to Improve Voiding Function and to Preserve Antegrade EjaculationYang S.S.-D.a · Tsai Y.-C.a · Chen J.-J.b · Peng C.-H.b · Hsieh J.-H.c · Wang C.C.b, c
aDepartment of Urology, Tzu Chi Buddhist Hospital, Taipei, and Medical School of Tzu Chi University, Hualien, bDepartment of Urology, En Chu Kong Hospital, College of Medicine, National Taiwan University, Taipei, and cDepartment of Biomedical Engineering, Chung Yuan Christian University, Chungli, Taiwan
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Objectives: To evaluate the voiding function, ejaculation status and sexual function after the novel modification of transurethral incision of the bladder neck (TIBN) treating young men with primary bladder neck obstruction (PBNO). Methods: Using a videourodynamic study, PBNO was diagnosed in 33 young men 27–50 years of age who presented with chronic lower urinary tract symptoms and low urinary flow. TIBN was performed in all patients, with the modification of preserving a portion of the supramontanal tissue during the procedure. International Prostate Symptom Score (I-PSS), quality of life, uroflowmetry, postvoid residual urine, the status of ejaculation and sexual function using the 5-item version of the International Index of Erectile Function (IIEF-5) were assessed before, 3 and 24 months after treatment. Results: Follow-up data were available in 32 (97%) and 26 (79%) patients at 3 and 24 months postoperatively, respectively. During the 2-year follow-up, mean I-PSS decreased from 20.7 to 5.9 (p < 0.01). Mean quality of life decreased from 4.2 to 2.3 (p < 0.01). Mean maximum flow increased from 10.7 to 19.2 ml/s (p < 0.01). Mean postvoiding residual urine decreased from 107 to 48 ml (p < 0.01). All patients had antegrade ejaculation postoperatively. Mean IIEF scores did not change significantly (22.6 ± 2.6 vs. 20.7 ± 4.3, p = 0.08). Successful overall outcome was achieved in 22 (84.6%) of 26 patients. Conclusions: Applying thismodified TIBN to treat the sexually active young men with PBNO had the advantage of improving voiding function and preserving both antegrade ejaculation and sexual function.
© 2008 S. Karger AG, Basel
- Kaplan SA, Ikeguchi EF, Santarosa RP, D’Alisera PM, Hendricks J, Te AE, et al: Etiology of voiding dysfunction in men less than 50 years of age. Urology 1996;47:836–839.
- Nitti VW, Lefkowitz G, Ficazzola M, Dixon CM: Lower urinary tract symptoms in young men: videourodynamic findings and correlation. J Urol 2002;168:135–138.
- Wang CC, Yang SSD, Chen YT, Hsieh JH: Videourodynamics identifies the causes of young men with lower urinary tract symptoms and low uroflow. Eur Urol 2003;43:386–390.
- Yang SSD, Wang CC, Hsieh CH, Chen YT: Alpha-1-adrenergic blockers in young men with primary bladder neck obstruction. J Urol 2002;168:571–574.
- Trockman BA, Gerspach J, Dmochowski R, Haab F, Zimmern PE, Leach GE: Primary bladder neck obstruction: urodynamic finding and treatment results in 36 men. J Urol 1996;156:1418–1420.
- Norlen LJ, Blaivas JG: Unsuspected proximal urethral obstruction in young and middle-aged men. J Urol 1986;135:972–976.
- Gil-Vernet JM Jr, Alvarez-Vijande R, Gil-Vernet A, Gil-Vernet JM: Ejaculation in men: a dynamic endorectal ultrasonographical study. Br J Urol 1994;73:442–448.
- Ronzoni G, De Vecchis M: Preservation of anterograde ejaculation after transurethral resection of both the prostate and bladder neck. Br J Urol 1998;81:830–833.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al: The standardization of terminology of lower urinary tract function: report from the standardization subcommittee of the International Continence Society. Neurourol Urodyn 2002;167:167–178.
Yang SSD, Hsieh CH, Chen YT: Combined use of Nd:YAG contact laser incision and non-contact coagulation necrosis in the treatment of benign prostatic hypertrophy – a preliminary report (in Chinese/Engl abstract). Formosan J Med 2000;4:1–7.
- Turner-Warwick R, Whiteside CG, Worth PHL, Milroy EJG, Bates CP: A urodynamic view of the clinical problems associated with bladder neck dysfunction and its treatment by endoscopic incision and trans-trigonal posterior prostatectomy. Br J Urol 1973;45:44–59.
- Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM: Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319–326.
- Homma Y, Kawabe K, Tsukamoto T, Yamaguchi O, Okada K, Aso Y, et al: Estimate criteria for efficacy of treatment in benign prostatic hyperplasia. Int J Urol 1996;3:267–273.
- Kaplan SA, Alexis ET, Jacobs BZ: Urodynamic evidence of vesical neck obstruction in men with misdiagnosed chronic nonbacterial prostatitis and the therapeutic role of endoscopic incision of the bladder neck. J Urol 1994;152:2063–2065.
- Abdel-Basir Sayed M: Bladder neck resection with preservation of antegrade ejaculation: basic technique. J Endourol 2003;17:109–111.
- Webster GD, Lockhart JL, Older RA: The evaluation of bladder neck dysfunction. J Urol 1980;123:196–198.
- Chahal R, Sundaram SK, Gogoi NK: Assessment of voiding outcome, sexual function and quality of life two years following KTP/YAG hybrid laser prostatectomy. Urol Int 2000;65:125–129.
- Tuhkanen K, Heino A, Aaltoma S, Ala-Opas M: Sexual function of LUTS patients before and after neodymium laser prostatectomy and transurethral resection of prostate. Urol Int 2003;73:137–142.
- Larson TR: Current treatment options for benign prostatic hyperplasia and their impact on sexual function. Urology 2003;61:692–698.
- Kochakarn W, Lertsithichai P: Unilateral transurethral incision for primary bladder neck obstruction: symptom relief and fertility preservation. World J Urol 2003;21:159–161.
- Ghobish A: Voiding dysfunction associated with chronic bacterial prostatitis. Eur Urol 2002;42:159–162.
- Hruz P, Danuser H, Studer UE, Hochreiter WW: Non-inflammatory chronic pelvic pain syndrome can be caused by bladder neck hypertrophy. Eur Urol 2003;44:106–110.
- Webb RJ, Griffith CJ, Zachariah K, Neal DE: Measurement of voiding pressure in men with bladder outflow obstruction studied by ambulatory monitoring and conventional urodynamic studies during natural and artificial bladder filling. J Urol 1991;146:815–818.
- Kuo HC: Pathophysiology of lower urinary tract symptoms in aged men without bladder outlet obstruction. Urol Int 2000;64:86–92.
- Ameda K, Koyanagi T, Nantani M, Taniguchi K, Matsuno T: The relevance of preoperative cystometrography in patients with benign prostatic hyperplasia: correlating the findings with clinical features and outcomes after prostatectomy. J Urol 1994;152:443–447.
- Yang SSD, Wang CC: Outpatient biofeedback relaxation of the pelvic floor in treating pediatric dysfunctional voiding: a short-course program is effective. Urol Int 2005;74:118–122.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.